This clinical practice guideline by the International Society for the Study of Women's Sexual Health provides evidence-based recommendations for the use of systemic testosterone therapy in postmenopausal women with hypoactive sexual desire disorder (HSDD). The guideline highlights testosterone's effectiveness in improving sexual desire and reducing distress related to low libido.
